SAHPRA requests industry comments on POST- MARKETING REPORTING OF ADVERSE DRUG REACTIONS TO HUMAN MEDICINES IN SOUTH AFRICA GUIDELINE

14 May 2019

Open  Amended Post-Marketing Reporting of Adverse Drug Reactions to Human Medicines in South Africa Guideline

Comment Period 14 May 2019 - 13 June 2019

Comments to be sent to adr@sahpra.org.za
[BACK TO News]